Investigational Trial to Evaluate XC001 Delivered Via an Cardiac Catheter in Subjects With Chronic Angina.

A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 106 participants.

Also called NCT07048808

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 106 participants (planned count) (from the registry)
Sponsor
XyloCor Therapeutics, Inc. (from the registry)
Registry
  • NCT NCT07048808
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07048808. Randomized; quadruple masking; primary purpose treatment. Start 2025-07-08 (actual); primary completion 2027-06-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Investigational Trial to Evaluate XC001 Delivered Via an Cardiac Catheter in Subjects With Chronic Angina.
Acronym
EXACT2
Condition
Refractory Angina
Intervention (Combination product)
XC001
Intervention (Combination product)
Sham (No Treatment)
Lead sponsor
XyloCor Therapeutics, Inc. (class: industry)

Record details

Record id
cardio:ct-nct07048808
Content hash
afc3407db2829d55951461556359ba52201f41675ff300b92c742dcf56cc8f5e